Microart Inc. (MCRT) Research

Established in 1980 and based in Kowloon City, Hong Kong, Microart Inc. is at the forefront of investigating and creating novel stem cell remedies and therapeutic applications for adult stem cells. The company also specializes in the development and market launch of cell-derived products for anti-aging and cosmetic sectors. Furthermore, Microart Inc. is dedicated to pioneering distinctive technological solutions for diabetes management.

Market snapshot

Symbol
MCRT
Price
$0.00
Day change
0.00%
Market cap
$26.1K
52-week range
0.0002-0.0002
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Curative Biosciences, Inc. (CBDX)
  • Core One Labs Inc. (CLABF)
  • Endonovo Therapeutics, Inc. (ENDV)
  • G Medical Innovations Holdings Ltd (GMVDF)
  • HAVN Life Sciences Inc. (HAVLF)
  • Kaleido Biosciences, Inc. (KLDO)
  • Nanobac Pharmaceuticals, Incorporated (NNBP)
  • Pazoo, Inc. (PZOO)

Open Microart Inc. (MCRT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.